Press releases

Reaching new heights

Reaching new heights

Origenis founds biotech Neuron23 in Silicon Valley together with star investor Kleiner Perkins

Origenis successfully establishes its new business model for the clinical development of its neuroprotective drug pipeline Martinsried ...

Origenis gründet mit Starinvestor Kleiner Perkins das Biotechunternehmen Neuron23 im Silicon Valley

Origenis etabliert damit erfolgreich ihr neues Geschäftsmodell zur klinischen Entwicklung ihrer neuroprotektiven Wirkstoffpipeline...

Neuron23 Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Klein

December 16, 2020 Biotechnology company launches to accelerate development of precision medicines for genetically defined neurological...